EGFR and non-small cell lung carcinoma: For example, in non-small cell lung cancer (NSCLC), circRNA_102231 was shown to be overexpressed in cases where NSCLC patients had resistance to gefitinib, an epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI)[12].